FILINGS
RARE 0001515673 | |||
---|---|---|---|
Filing Date | Form Type | Description | Document |
2025-04-24 | SCHEDULE 13G/A | null | View Document |
2025-03-28 | ARS | ANNUAL REPORT TO SECURITY HOLDERS | View Document |
2025-03-28 | DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | View Document |
2025-03-28 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
2025-03-10 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-04 | 4 | 4 | View Document |
2025-03-03 | 4 | 4 | View Document |
2025-02-28 | 144 | View Document | |
2025-02-27 | 144 | View Document | |
2025-02-19 | 10-K | 10-K | View Document |
2025-02-13 | 8-K | 8-K | View Document |
2025-02-12 | SCHEDULE 13G/A | View Document | |
2025-02-10 | SCHEDULE 13G/A | View Document | |
2025-01-13 | 8-K | 8-K | View Document |
2024-12-31 | 4 | 4 | View Document |
2024-12-30 | 144 | View Document | |
2024-12-19 | 8-K | 8-K | View Document |
2024-12-19 | 8-K | 8-K | View Document |
2024-12-11 | 4 | 4 | View Document |
2024-12-11 | 4 | 4 | View Document |
2024-12-10 | 144 | View Document | |
2024-11-14 | SC 13G/A | ULTRAGENYX PHARMACEUTICAL INC. | View Document |
2024-11-12 | 8-K | 8-K | View Document |
2024-11-06 | 10-Q | 10-Q | View Document |
2024-11-05 | 8-K | 8-K | View Document |
2024-10-11 | 4 | 4 | View Document |
2024-10-07 | 8-K | 8-K | View Document |
2024-10-03 | 8-K | 8-K | View Document |
2024-09-18 | 4 | 4 | View Document |
2024-09-05 | 4 | 4 | View Document |
2024-09-05 | 4 | 4 | View Document |
2024-09-03 | 144 | View Document | |
2024-08-07 | 4 | 4 | View Document |
2024-08-06 | 144 | View Document | |
2024-08-02 | 10-Q | 10-Q | View Document |
2024-08-01 | 8-K | 8-K | View Document |
2024-07-17 | 8-K | 8-K | View Document |
2024-07-12 | S-8 | S-8 | View Document |
2024-07-03 | 4 | 4 | View Document |
2024-07-02 | 144 | View Document | |
2024-06-21 | 8-K | 8-K | View Document |
2024-06-20 | 4 | 4 | View Document |
2024-06-20 | 4 | 4 | View Document |
2024-06-20 | 4 | 4 | View Document |
2024-06-20 | 4 | 4 | View Document |
2024-06-20 | 4 | 4 | View Document |
2024-06-20 | 4 | 4 | View Document |
2024-06-20 | 4 | 4 | View Document |
2024-06-17 | 8-K | 8-K | View Document |
2024-06-14 | 424B5 | 424B5 | View Document |
2024-06-12 | 4 | 4 | View Document |
2024-06-12 | 424B5 | 424B5 | View Document |
2024-06-12 | 144 | View Document | |
2024-06-12 | 8-K | 8-K | View Document |
2024-06-12 | 8-K | 8-K | View Document |
2024-06-10 | 4 | 4 | View Document |
2024-06-10 | 144 | View Document | |
2024-06-10 | UPLOAD | View Document | |
2024-05-30 | 8-K | 8-K | View Document |
2024-05-17 | CORRESP | View Document | |
2024-05-03 | 4 | 4 | View Document |
2024-05-03 | 10-Q | 10-Q | View Document |
2024-05-02 | 8-K | 8-K | View Document |
2024-04-26 | ARS | ULTRAGENYX PHARMACEUTICAL INC. - ARS | View Document |
2024-04-26 | DEFA14A | ULTRAGENYX PHARMACEUTICAL INC. - DEFA14A | View Document |
2024-04-26 | DEF 14A | ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A | View Document |
2024-04-22 | UPLOAD | View Document | |
2024-04-19 | 4 | 4 | View Document |
2024-04-18 | 4 | 4 | View Document |
2024-04-15 | 8-K | 8-K | View Document |
2024-03-12 | 4 | 4 | View Document |
2024-03-11 | 144 | View Document | |
2024-03-11 | 4 | 4 | View Document |
2024-03-07 | 144 | View Document | |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-03-05 | 4 | 4 | View Document |
2024-02-21 | S-3ASR | S-3ASR | View Document |
2024-02-21 | 10-K | 10-K | View Document |
2024-02-15 | 8-K | 8-K | View Document |
2024-02-14 | SC 13G/A | View Document | |
2024-02-14 | SC 13G/A | ULTRAGENYX PHARMACEUTICAL INC. | View Document |
2024-02-13 | SC 13G/A | SCHEDULE 13G/A | View Document |
2024-02-13 | SC 13G | View Document | |
2024-02-08 | 4 | FORM 4 SUBMISSION | View Document |
2024-02-08 | SC 13G/A | SEC SCHEDULE 13G | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.